Connect with us

Press Releases

Transitions Optical Announces the Launch of Transitions Signature GEN 8

It incorporates a fully reinvented system which has not been done since the launch of Transitions V lenses in 2005.

mm

Published

on

(PRESS RELEASE) Transitions Optical has announced details on the upcoming launch of the next generation of Transitions Signature lenses – Transitions Signature GEN 8. Transitions Signature GEN 8 lenses are engineered with new proprietary technology, that delivers the best overall photochromic lens performance.

The next generation of Transitions Signature lenses comes six years after the launch of Transitions Signature VII lenses with a new, breakthrough technology. The performance of photochromic lenses is linked to two components: the matrix in which the dyes reside and the photochromic dyes themselves. The Transitions Signature GEN 8 lens technology incorporates a fully reinvented system, including a reinvented matrix and new photochromic dyes, which has not been done since the launch of Transitions V lenses in 2005.

Technology

Transitions Signature GEN 8 lenses are the result of five years of research and development involving more than 100 people. Transitions Signature GEN 8 lenses were developed using new, breakthrough technology that combines a disruptive nanocomposite matrix and a new generation of ultra-agile photochromic dyes. The nano-composite matrix in Transitions Signature GEN 8 lenses is a nano-structured material which mimics a semi crystalline structure. This matrix creates free zones for improved dye mobility. Not only can the dyes move more freely, but it is also more stable and consistent in its performance.

Performance

The new Transitions Signature GEN 8 lens technology allows a new frontier of performance, without compromise. Not only are Transitions Signature GEN 8 lenses faster in activation and fadeback, they are even darker than previous generations. The lenses also block 100% UV and help protect from harmful blue light indoors and out. As a consequence, Transitions Signature GEN 8 lenses are the besti overall photochromic lenses. A new multi-criteria methodology was developed to assess the overall performance of photochromic lenses. This methodology is based on market research done in the U.S. among 1,000 eyeglass wearers, defining the key criteria that matter most for consumers on photochromic lenses.

Advertisement

Aspiration

“As leader and champion of the photochromic category, our mission is to provide better vision and protection to everyone. We are proud to introduce a new technology, bringing a new level of performance, based on consumer’s needs. With Transitions Signature GEN 8 we are confident that we will recruit new wearers and grow the category” Chrystel Barranger, president of Essilor Photochromics and Transitions Optical.

Transitions Signature GEN 8 lenses will launch in the U.S. in July 2019 and in the Fall in Canada.

Advertisement

SPONSORED VIDEO

SPONSORED BY SAFILO

Safilo’s “American Eyes” Video Celebrates Elasta and Emozioni starring ECPs Peter Tacia and Heidi Dancer

For the third year in a row, Safilo has looked to trusted eyecare professionals to star in its American Eyes campaign for its Elasta and Emozioni collections.Their latest testimonials are from Peter Tacia, O.D. and Heidi Dancer, optician, of Alma, MI, talking about two best-selling collections: Elasta and Emozioni.

Promoted Headlines

Press Releases

Morel’s Wins the 25th Annual Communicator Award of Excellence

It wins the award in the B2B category.

mm

Published

on

(PRESS RELEASE) WYCKOFF, NJ — Morel, the French reference in eyewear, established in 1880, is very excited to receive a Communicator Award for the 2018 B2B campaign, See More, See Morel.

This international award was granted in recognition of Morel’s 360° communication campaign, launched at Silmo 2018. The new campaign features circles that are multicolor and fun, leaving an everlasting footprint. More than just an image, the circles blend Morel’s rich heritage and expertise in designs.

The Morel team is honored to accept the award and be on the lookout for the See More, See Morel campaign on Morel’s advertisements.

Continue Reading

Press Releases

Marcolin Group Announces Operational Changes

This is part of an agreed-upon plan between the parties involved.

mm

Published

on

Giovanni Zoppas

(PRESS RELEASE) LONGARONE, BL — Marcolin Group, one of the worldwide leading eyewear companies, announces that Giovanni Zoppas is leaving his responsibilities in the group, while still remaining as a director of the board.

Giovanni Zoppas moves on to Thélios in the role of CEO and general manager of the joint venture established by Marcolin with the LVMH Group.

This is part of an agreed-upon plan between the parties, aimed at maximizing the overall value of Marcolin Group.

Continue Reading

Press Releases

House Subcommittee Urges FTC to Modernize Contact Lens Verification Process

Patient safety advocates have repeatedly called attention to flaws in current rules related to prescription verification.

mm

Published

on

(PRESS RELEASE) WASHINGTON – The Health Care Alliance for Patient Safety (Alliance) this week expressed its support of the House Committee on Appropriations for urging the Federal Trade Commission (FTC) to update the process by which contact lens prescriptions are verified.

The Committee report, which accompanies the Financial Services and General Government (FSGG) funding bill, comes as the FTC is accepting additional public comments on the proposed Contact Lens Rule. Patient safety advocates have repeatedly called attention to flaws in current rules related to prescription verification.

The FSGG report, which can be read here, states:

Contact Lenses. — In May, the FTC released a Supplemental Notice of Proposed Rulemaking detailing potential adjustments to its proposed changes to the Contact Lens Rule. This ensures that the FTC will receive additional input from the public and stakeholders on potential improvements to the rule to address patient safety and enforcement mechanisms, among other issues. The Committee urges the FTC to address the need for the prescription verification process to be modernized to provide for adequate enforcement of the law.

Thomas Swinnen, North America President of Johnson & Johnson Vision Care, Inc. and member of the Alliance, stated, “This report language reflects the importance of amplifying patient eye health and safety issues with policymakers. We’re pleased that the Committee recognizes the need to modernize the prescription verification process—a critical step in maintaining the doctor-patient relationship at the center of patient care.”

For several years, Alliance members and patient safety advocates have called for updated verification methods that would ensure patients receive the proper medical devices they were prescribed by their eye care professional.

In 2018, the Alliance submitted comments to the FTC that highlighted the problems with the current prescription verification system. The comments read, in part, “FTC action to modernize its guidance around passive-verification communication while excluding antiquated technology (e.g. robocalls) would provide greater documentation and the possibility of greater oversight in the [prescription] verification process. Greater oversight, understanding and documentation will ultimately create a safer and more efficient environment for contact lens wearers and the verification of their prescriptions through clearer, concise and accurate communication between the prescriber and the seller.”

“The doctor-patient relationship is central to the widespread enjoyment of contact lenses. A key part of that equation is ensuring what was prescribed is ultimately provided, as each contact lens is precisely selected for a patient’s specific vision and health needs,” said Michele Andrews, OD, Senior Director, North American Professional & Academic Affairs, CooperVision. “We are committed to advancing healthy contact lens wear for millions of consumers and encourage the FTC to share in this responsibility by addressing and fixing outmoded verification techniques.”

The Alliance encourages patients to share their stories of how antiquated technology in the prescription verification process has been detrimental to their vision health. To share your story and tell the FTC to protect patient safety, visit www.PatientSafetyToday.com/Share_Your_Story.

Deanna Alexander, OD, chairwoman of the Alliance, concluded, “For a significant period of time, patient safety advocates, like the members of the Alliance, have shared the potential dangers that could stem from the FTC’s current rules related to contact lens prescription verification. Now, as Congress makes it clear that they believe it’s time for a verification system that protects patients’ vision health, the Alliance is hopeful that the FTC will carefully consider adjustments to the Contact Lens Rule to better safeguard patients.”

Continue Reading

Advertisement

Advertisement

Advertisement

Subscribe


BULLETINS

Get the most important news and business ideas for eyecare professionals every weekday from INVISION.

Instagram

Most Popular